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1015-9584/Copyright ª 2015, Asian SuSummary Objective: There are controversies about the benefits of prophylactic antibiotics
in the prevention of postoperative surgical site infection (SSI) in mesh herniorrhaphy for a long
time. This study aimed to evaluate the effectiveness and efficacy of systemic prophylactic ce-
fazolin in prevention of wound infection in various types of hernia repair with mesh materials.
Methods: This is a prospective randomized control study. We evaluated wound infection rates
in 395 patients with various kinds of hernia who underwent elective mesh repair using polypro-
pylene mesh from 2007 to 2011. A total of 237 (60.0%) patients received prophylactic cefazolin
(study group) and the remaining 158 (40.0%) patients did not receive any prophylactic antibi-
otics (control group). Patients were followed for infection at the following periods after the
operation by an independent surgeon: 10 days, 30 days, 12 months, and then annually for at
least 2 years.
Results: Eight (2.03%) patients had infection in the site of surgery [2 (1.27%) in the control
group and 6 (2.53%) in the study group]. The distribution of infection was not significantly
different between the two groups (p Z 0.364). The superficial infections were managed by
drainage and irrigation. One patient from the study group developed deep SSI and was read-
mitted and subsequently received antibiotic therapy, drainage, and debridement.
Conclusion: Preoperative administration of single-dose cefazolin for prosthetic hernia repairs
did not markedly decrease the risk of wound infection. Our results do not support the use ofeclare no conflicts of interest.
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reserved.1. Introduction
Abdominal wall hernia is defined as an abnormal protrusion
of an organ through actual anatomic weaknesses or de-
fects. The most commonly involved sites are the inguinal
and femoral region (75%), umbilical and epigastric region
(10%), and midline and sites of prior incisions (15e20%). The
actual incidence of incisional hernia is unknown but 3e20%
of laparotomies performed annually may result in ventral
hernia.1
Inguinal hernia’s lifetime risk is 27% and 3% in men and
women, respectively. In the field of general surgery, hernia
repair is one of the most common and important operations
performed because of the significant lifetime incidence of
hernia and availability of a variety of successful treatment
procedures.1,2 After the introduction of prosthetic material
for hernia repair, because of its role in reduction of
recurrence rate between 50% and 75% and simple per-
formance,3e5 mesh repair has been worldwide accepted as
the gold standard in the elective management of inguinal
hernia types.6 Various mesh herniorrhaphy techniques
include tension-free reconstruction of the posterior
inguinal canal with anterior approach (Lichtenstein),
anterior preperitoneal repairs through standard groin inci-
sion (Read-Rives) or through lower midline incision
(Stoppa), and Rives procedure in which the prosthesis is
placed between the rectus abdominis muscle and the pos-
terior sheath.6 Although the hernia repair operations are
considered clean procedures, surgical site infections (SSIs)
are common complications, leading to increases in length
of hospitalization and costs. The incidence of SSI after
these surgeries varies from 1.7% to 14% that can be influ-
enced by the location of incision, elective or emergent
condition, length of operation, surgical techniques
including poor closure, tissue trauma, wound contamina-
tion, hemostasis, tissue damage, diabetes, chronic steroid
use, smoking, malnutrition, obesity, prior hernia incision
infections, foreign material in surgical site, chronic skin
infections, and other site infections.5,7e10
The infection can produce pain and lead to poor wound
healing and increases in hospital stay and costs. The risk of
infection can be decreased using a proper operative tech-
nique, decreasing operative time, using a preoperative
antiseptic skin cleaner, and by appropriate shaving.1,7e9
Although several studies were performed to evaluate the
benefits of different kinds of antibiotics in prevention of
postoperative SSI after inguinal mesh herniorrhaphy, their
role remains controversial.7,11e15
To our knowledge, only a few studies evaluated the role
of prophylactic antibiotics in preventing postoperative SSI
after repair of other types of abdominal wall hernia with
mesh.16 Thus, this study aimed to evaluate theeffectiveness and efficacy of systemic prophylactic cefa-
zolin in the prevention of wound infection in various types
of hernia repair with mesh materials.
2. Patients and methods
This is a prospective randomized control study, which was
performed to evaluate the effectiveness and efficacy of
systemic prophylactic cefazolin in the prevention of post-
operative wound infection in various hernia repairs with
mesh materials. Participants included 395 patients with
various kinds of hernia (inguinal, femoral, bilateral, inci-
sional, umbilical, and lumbar hernias) who were candidates
for elective mesh repair in Imam Reza Hospital, Mashhad
University of Medical Sciences, Mashhad, Iran from
September 2007 to October 2011. We excluded the
following: patients undergoing emergency operations;
immunocompromised patients with underlying diseases
such as renal failure, cirrhosis, diabetics, malignancy;
corticosteroid and immunosuppressive drug users; patients
with use of preoperative antibiotics for different reasons >
1 week prior to surgery; patients’ allergy to antibiotics; and
patients under the age of 18 years. All patients were rec-
ommended to take a bath the night prior to surgery.
Based on an alternate-day randomization system, after
anesthesia administration prior to the incision, the study
group received 50 mL sterile saline with 1 g intravenous
cefazolin. The control group did not receive any antibiotics.
Cefazolin was chosen because of its bactericidal activity
against the pathogenic organisms in skin wound infections.
The half-life time of cefazolin is 1.5e2.5 hours, and
therefore, it will have effective therapeutic levels during
the course of the procedure. In the operating room, after
shaving the surgical site and completion of skin preparation
with povidoneeiodine solution, we used a plastic sterile
drape over the surgical site. All patients received general
anesthesia. The following operation procedures were per-
formed: Lichtenstein [in 58 (14.7%) patients], Read-Rives
[in 52 (13.2%) patients], Stoppa [in 143 (36.2%) patients],
and Rives [in 142 (35.9%) patients].
The mesh material was a monofilament polypropylene
mesh (Promesh Light, Pe’ters Surgical, France) whose size
varied from 6 cm  11 cm to 30 cm  30 cm. Based on the
size of the hernia, at least 10 cm overlap of the mesh with
margins of abdominal wall defect was considered. The
closed suction drains were used in all Stoppa and Rives
procedures. In addition, the wound closure was performed
with running subcuticular suture.
If there was no event in the postoperative period, pa-
tients were discharged from the hospital according to the
surgeon’s discretion. Drains were removed when the 24-
hour drainage decreased below 40e50 cm3/d.
Table 2 Distribution of type of hernia in each group
(p < 0.001).
Prophylactic
antibiotic
Epigastric Incisional Inguinal Umbilical Total
No 3 (1.9) 7 (4.5) 138 (87.9) 9 (5.7) 157
Yes 7 (2.9) 94 (39.5) 115 (48.3) 22 (9.2) 238
Total 10 (2.5) 101 (25.6) 253 (64.1) 31 (7.8) 395
Data are presented as n (%).
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Thereafter, all patients were followed by telephone call and
only 128 (32.3%) patients who reported complaints were
visited. The patients were followed on Day 10, Day 30, and 12
months after the operation for signs of infection, recurrence,
edema, and hematoma. The patients were visited and their
data were collected by a surgeon who was not involved in
surgery. Infection was described when the incision became
erythematous and tender or had purulent discharge up to 1
year. In these situations the stitches were removed, the
wound was irrigated with saline, and the depth of infection
and mesh involvement was determined. In cases of deep
infection (mesh infection), the wound was opened, and then
it was irrigated. After mesh debridement, a delayed closure
was planned. Postoperative complications such as seroma,
hematoma, and urinary fistula were recorded throughout the
follow-up period for at least 2 years after the surgery.
Descriptive statistics such as frequency and percentage
were used for categorical data and the mean and standard
deviation for numerical variables. Statistical inferences
such as independent sample t (student), Chi-square, and
Fisher exact tests were performed to check the significant
difference or the association between the variables.
3. Results
In this study, 395 patients with different kinds of hernia
selected to receive elective surgery were enrolled. Of
them, 278 (70.4%) were male and 117 (29.6%) were female
with the mean age of 52.43  16.57 years (Table 1). Based
on an alternate-day randomization system, patients were
assigned to the study and control groups. Two hundred and
thirty seven (60.0%) patients (study group) received pro-
phylactic cefazolin, and the remaining 158 (40.0%) patients
did not receive any prophylactic antibiotics (control group).
The mean age of patients in the control group was
50.6  17.83 years and 53.67  15.59 years in the study
group, which was not significantly different (p Z 0.078).
The frequency distribution of sex in the two groups is pre-
sented in Table 1. There was a significant difference be-
tween sex and use of prophylactic cefazolin (p < 0.001).
Two (0.5%) patients had abdominal wall endometriosis,
10 (2.5%) patients had epigastric hernia, 101 (25.6%) pa-
tients had incisional hernia, 31 (7.8%) patients had umbili-
cal hernia, and 253 (64.1%) patients had inguinal hernia
(Table 2). Seventy-one (18.0%) patients had recurrent her-
nia with a history of previous operation: 15 (21.1%) patientsTable 1 Patients characteristics in each group.
Characteristics Control (n Z 1
Mean Age  SD 53.67  15.59
Sex Male 136 (86.1)
Female 22 (13.9)
Type of operation Lichtenstein 37 (23.4)
Rives 18 (11.4)
Read-Rives 33 (20.9)
Stoppa 70 (44.3)
Data are presented as n (%) or mean  SD.with incisional hernia, 46 (64.8%) with inguinal hernia, and
10 (14.1%) with umbilical hernia.
The most common incisions were midline [66 (44.0%)],
inguinal [46 (30.7%)], and Pfannenstiel [13 (8.7%)]. Stoppa
was the most common technique performed [143 (36.2%)
patients]. Other procedures were Lichtenstein [58 (14.7%)
patients], Rives [142 (35.9%) patients], and Read-Rives [52
(13.2%) patients; Table 1].
Drains were removed when the 24-hour drainage
decreased < 40e50 cm3/d. However, unfortunately, dura-
tion of drains left in situ was not recorded.
The mean hospital stay was 3.1  0.7 days. The reason
for this seemingly high mean hospital stay is due to the
insertion of drains in patients receiving Rives or Stoppa
techniques (55.7%) who were discharged after removal of
the drains.
As shown in Table 3, in the postoperative period, 26
(6.6%) patients had a complaint of pain, six (1.5%) patients
had hematoma, and six (1.5%) patients had seroma forma-
tion. There was no significant difference between the two
groups in the types of complications (p > 0.05). All seromas
were confined to the area of the incision and diagnosed by
aspiration of clear serous fluid, and were managed expec-
tantly without sequelae. Only one (0.3% of total) patient in
the study group developed urinary fistula after Stoppa,
which was characterized by the exit of urine from the drain.
The patient was managed conservatively with catheteriza-
tion without the need for prosthesis removal. Eight (2.03%)
patients had an infection in the site of surgery [2 (1.27%) in
the control group and 6 (2.53%) in the study group], all
detected during the follow-up period. The distribution of
infection was not significantly different between the two
groups (pZ 0.364). The distribution of superficial infection
was as follows: four patients who received Rives, one pa-
tient who received Read-Rives, and two patients who
received Stoppa repairs. There was no significant difference58, 40.0%) Study (n Z 237, 60.0%) p
50.6  17.83 0.078
142 (59.9) <0.001
95 (40.1)
21 (8.9) <0.001
124 (52.3)
19 (8.0)
73 (30.8)
Table 3 Postoperative complications in each group.
Type of
complications
Control
(n Z 158, 40.0%)
Study
(n Z 237, 60.0%)
p
Pain No 148 (93.7) 221 (93.2) 0.868
Yes 10 (6.3) 16 (6.8)
Hematoma No 156 (98.7) 233 (98.3) 0.734
Yes 2 (1.3) 4 (1.7)
Seroma
formation
No 154 (97.5) 235 (99.2) 0.184
Yes 4 (2.5) 2 (0.8)
Urinary
fistula
No 158 (100.0) 236 (99.6) 0.312
Yes 0 (0.0) 1 (0.4)
Wound
infection
No 156 (98.7) 230 (97.5) 0.364
Yes 2 (1.3) 6 (2.5)
DSSI 0 (0.0) 1 (16.7) 0.430
SSSI 2 (100.0) 5 (83.3)
Data are presented as n (%).
DSSI Z deep surgical site infection; SSSI Z superficial surgical
site infection.
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One (0.25%) patient who received Rives repair in the study
group developed deep SSI, which necessitated readmission
and partial debridement of the mesh without complete
excision. Cultures showed aerobic Gram-positive strepto-
cocci organisms. These patients underwent wound drainage
and infected prosthesis were subjected to drainage,
debridement, and antibiotic therapy without the need for
complete mesh removal (Table 4). In the follow-up period,
only two (0.5%) patients of the study group (who received
the Stoppa procedure) had recurrence in the site of surgery,
which was not significantly different (p Z 0.519).
4. Discussion
The true incidence of incisional hernia is unknown but in
general 3e20% of laparotomies annually may result in
ventral hernia; the rate doubles if the operation is associ-
ated with an SSI and wound dehiscence.1 Inguinal hernia
surgery has evolved drastically since first performed in
ancient Egypt (from simple tissue repairs with suture to
tension-free repairs with prosthetic materials) in parallelTable 4 Details of infected patients.
Patient No. Group Type of
operation
Microorganism cultured
1 Study Rives S. epidermidis
2 Study Rives S. epidermidis
3 Study Rives S. epidermidis
4 Study Rives S. epidermidis
5 Study Rives S. aureus and S. epidermi
6 Study Read-Rives S. epidermidis
7 Control Stoppa S. epidermidis
8 Control Stoppa S. epidermidis
DSSI Z deep surgical site infection; S. aureus Z Staphyloco
SSSI Z superficial surgical site infection.with the development of our anatomical understanding and
improvements in surgical techniques.4 Hernia repair using
mesh was introduced 50 years ago. With the development
of advanced methods, mesh was used for a variety of pri-
mary and recurrent hernias of the abdominal wall. Some of
the methods of repair used are Lichtenstein, Read-Rives,
Stoppa, Rives, and laparoscopic mesh repair. In addition,
different mesh materials have been introduced. After
installation of the mesh, the fibroblasts penetrate the mesh
and after some days it becomes completely infiltrated with
connective tissue. Based on the material of the mesh, the
time of this infiltration varies.17
Seroma formation and implementation of foreign bodies
such as prosthesis are two important risk factors associated
with the high risk of bacterial contamination and infection,
which may ultimately lead to significant morbidity (mesh
removal and possible recurrence) and also mortality.
The incidence rate of infection following an inguinal
herniorrhaphy, with or without prosthesis material, is be-
tween 1.7% and 14%.5,7,10
Because many factors influence the risk of wound
infection, it is not possible to eliminate the infection
completely; but infections can be reduced by improving
surgical conditions and using proper equipment.
Along with the application of prosthetic mesh, prophy-
lactic antibiotics were also traditionally used to prevent
postoperative SSI. However, because of the low risk of
wound infection and high incidence of drug resistance and
side effects of antibiotics, the role of antibiotics in this
regard is still a matter of debate.10
Considering the high rate of abdominal wall hernia
repair annually performed worldwide, prevention of
infection is so important.
For a long time, several studies advocated the benefits
of different kinds of antibiotics (such as cefazolin, ampi-
cillin/sulbactam, and amoxicillin/clavulanic acid) in pre-
vention of postoperative SSI after inguinal mesh
herniorrhaphy.7,11e16 To our knowledge, there are only a
few studies that evaluated the role of prophylactic antibi-
otics in postoperative SSI after abdominal incisional hernia
repair using mesh.16 By contrast, some studies demon-
strated that antibiotic prophylaxis in elective inguinal
hernia repair with mesh cannot decrease the risk of wound
infection.5,18e21Type of infection Management Outcomes
SSSI Drainage Recovered
SSSI Drainage Recovered
SSSI Drainage Recovered
SSSI Drainage Recovered
dis DSSI Antibiotics, drainage,
and debridement
Recovered
SSSI Drainage Recovered
SSSI Drainage Recovered
SSSI Drainage Recovered
ccus aureus; S. epidermidis Z Staphylococcus epidermidis;
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meta-analysis of 13 randomized trials that evaluated the
benefits of antibiotic prophylaxis in inguinal hernia repair;
of these 13 trials, seven used a prosthetic material. A total
of 6825 patients were included (4188 in the prophylaxis
group and 2637 in the control group). The rate of infection
in patients with hernioplasty was 1.4% and 2.9% in the
prophylaxis and control groups, respectively. Based on
these results, the authors recommended the use of anti-
biotics only in cases with high rates of wound infections,
and not universally for all patients undergoing elective
inguinal hernia repair.5 Perez and colleagues22 also per-
formed a prospective, randomized, double-blind, placebo-
controlled trial to compare single-dose 1 g intravenous
cefazolin with placebo in 360 patients undergoing open
inguinal hernia using polypropylene mesh. Their results
also showed no benefit of antibiotic prophylaxis (1.7% vs.
3.3%, p Z 0.50).
Another double-blind prospective randomized trial in
200 patients selected to receive elective inguinal hernia
surgery with mesh repair demonstrated no significant dif-
ference between the cefazolin and placebo groups (7% in
the study group and 5 % in the placebo group, p Z 0.38).
They concluded that antibiotic prophylaxis has no benefit in
the incidence of SSI in elective repair of inguinal hernias
with mesh.18
Similar results were documented by Jain et al,19 Tzo-
varas et al,20 and Aufenacker et al,21 which did not support
the use of prophylactic antibiotics in low-risk patients with
inguinal mesh hernioplasty.
The nationwide Danish Hernia Database, which records
> 10,000 inguinal and 400 femoral hernia repairs annually,
suggests that routine prophylactic antibiotics are not
indicated.23
Antibiotics used for prophylaxis should be safe, cost-
effective, and effective against common pathogens based
on procedure type. Therefore, in accordance with previous
studies we used cefazolin because of its bactericidal ac-
tivity against the pathogenic organisms in skin wound
infection. The majority of the studies were on inguinal
hernia repair, and there were only a few reports that
studied the relationship between prophylactic antibiotics
and extent of hernia site, prosthesis size, operation time,
and extent of tissue dissection. Increase in the size of the
hernia leads to an extended dissected area, and conse-
quently larger size of mesh and increased operative time.
All these factors predispose the wound to seroma forma-
tion, increased bacterial contamination, and decreased
prosthesis adhesion to tissue due to a delay in fibroblast
migration, and ultimately prosthesis infection.17
Some important risk factors mentioned earlier such as
hernia site and prosthesis size were considered in the
design of our study to evaluate the role of cefazolin as
prophylaxis for postoperative wound infection. Unfortu-
nately, other risk factors such as the mean operating time,
obesity, and history of smoking were not considered in this
study.
Seroma formation was noted in four (2.5%) patients in
the control group and in two (0.8%) patients in the study
group, and none of them progressed to SSI. Hematoma
formation was noted in 0.01% of patients with no progres-
sion to wound infection.The overall risk of infection was 2.03%, which was similar
to other studies.5,7,10 The rate of wound infection was 2.5%
in the study group versus 1.3% in the control group with no
significant difference between the two groups (pZ 0.364).
Based on the Chi-square test, there was no significant
difference regarding infection between patients who
received Rives and Read-Rives repair (p Z 0.219).
One patient in the study group developed deep SSI.
Although there was no significant difference between the
two groups, cefazolin does not seem to have any beneficial
effects in prevention of wound infection.
In some studies, deep SSI eventually led to graft
loss,13,22 but in our study the infected prosthesis was sub-
jected to debridement without the need for graft removal.
The European Hernia Society guideline for inguinal
repair recommended antibiotic prophylaxis in the presence
of wound infection risk factors such as recurrence,
advanced age, immunosuppressive conditions and steroid
use, emergency conditions, long operating duration, and
use of drains; it is not recommended for low-risk patients
(< 5%) and in endoscopic hernia repair.24
In conclusion, with regard to an outbreak of bacterial
resistance and less cost effectiveness of prophylactic an-
tibiotics, our results suggest that preoperative administra-
tion of cefazolin does not decrease the risk of
postoperative wound infection in low-risk patients, and
thus, does not support the use of cefazolin prophylaxis for
mesh hernia repair.
Finally, because of the low infection rate in this study, it
was not possible to evaluate the impact of factors such as
previous history of hernia repair, hernia site, the extent of
dissection, mesh size, and length of operation on wound
infection. Thus, future studies with a larger sample size are
needed to evaluate these factors.Acknowledgments
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